Health News

ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, is today issuing a business update for the period ending 30 September, 2009.

Read more

Filed under: Pharmacy News
Tags: cancer, Eye Disease, medicine, Pharmacy

Related posts

• ThromboGenics initiates Phase II trial of microplasmin for wet AMD (0)
  ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, announces today that it has started a Phase II trial of microplasmin for the treatment of exudative (wet) Age-related Macular Degeneration (AMD). Read more [tags] Pharmacy News [/tags]
  
  
• ThromboGenics Announces Results From A Phase IIa Trial Evaluating Microplasmin For The Treatment Of Diabetic Macular Edema (MIVI II DME) (0)
  ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative medicines for eye disease, vascular disease and cancer, today announces results of a Phase IIa trial evaluating microplasmin intravitreal injection for the treatment of Diabetic Macular Edema (MIVI II DME). Read more [tags] Pharmacy News [/tags]
  
  
• Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine (0)
  Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has requested Scientific Advice from the European Medicines Agency (EMA) to assure the acceptability of the recently initiated Phase 3 programs for the development of its lead anticancer compound, perifosine, in its two lead indications, multiple myeloma [...]
  
  
• When To Administer Food And Drugs Together (0)
  A regulatory bias against taking oral anti-cancer medications with food places many patients at increased risk for an overdose and forces them to "flush costly medicines down the toilet," argues Mark Ratain, MD, an authority on cancer-drug dosing. In a commentary published early online Sept. 19 in the Journal of Clinical Oncology, Ratain, the Leon [...]
  
  
• What Is Herceptin (trastuzumab)? What Is Herceptin For? (0)
  Herceptin is the brand name of a medicine called trastuzumab. This medicine can stop the growth of breast cancer and sometimes reduce the size of the tumor. Herceptin is given by a drip into a vein. It can be given in combination with chemotherapy, or on its own to patients who have already had [...]